TY - JOUR AU - Lachenal, F. AU - Cotton, F. AU - Desmurs-Clavel, H. AU - Haroche, J. AU - Taillia, H. AU - Magy, N. PY - 2006 DA - 2006// TI - Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature JO - J Neurol VL - 253 UR - https://doi.org/10.1007/s00415-006-0160-9 DO - 10.1007/s00415-006-0160-9 ID - Lachenal2006 ER - TY - JOUR AU - Arnaud, L. AU - Hervier, B. AU - Neel, A. AU - Hamidou, M. A. AU - Kahn, J. E. AU - Wechsler, B. PY - 2011 DA - 2011// TI - CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-06-294108 DO - 10.1182/blood-2010-06-294108 ID - Arnaud2011 ER - TY - JOUR AU - Drier, A. AU - Haroche, J. AU - Savatovsky, J. AU - Godeneche, G. AU - Dormont, D. AU - Chiras, J. PY - 2010 DA - 2010// TI - Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings JO - Radiology VL - 255 UR - https://doi.org/10.1148/radiol.10090320 DO - 10.1148/radiol.10090320 ID - Drier2010 ER - TY - JOUR AU - Albayram, S. AU - Kizilkilic, O. AU - Zulfikar, Z. AU - Islak, C. AU - Kocer, N. PY - 2002 DA - 2002// TI - Spinal dural involvement in Erdheim-Chester disease: MRI findings JO - Neuroradiology VL - 44 UR - https://doi.org/10.1007/s00234-002-0853-4 DO - 10.1007/s00234-002-0853-4 ID - Albayram2002 ER - TY - JOUR AU - Curgunlu, A. AU - Karter, Y. AU - Ozturk, A. PY - 2003 DA - 2003// TI - Erdheim-Chester disease: a rare cause of paraplegia JO - Eur J Intern Med VL - 14 UR - https://doi.org/10.1016/S0953-6205(02)00208-X DO - 10.1016/S0953-6205(02)00208-X ID - Curgunlu2003 ER - TY - JOUR AU - Takeuchi, T. AU - Sato, M. AU - Sonomura, T. AU - Itakura, T. PY - 2012 DA - 2012// TI - Erdheim-Chester disease associated with intramedullary spinal cord lesion JO - Br J Radiol VL - 85 UR - https://doi.org/10.1259/bjr/65720693 DO - 10.1259/bjr/65720693 ID - Takeuchi2012 ER - TY - JOUR AU - Haroche, J. AU - Arnaud, L. AU - Amoura, Z. PY - 2012 DA - 2012// TI - Erdheim-Chester disease JO - Curr Opin Rheumatol VL - 24 UR - https://doi.org/10.1097/BOR.0b013e32834d861d DO - 10.1097/BOR.0b013e32834d861d ID - Haroche2012 ER - TY - JOUR AU - Aouba, A. AU - Georgin-Lavialle, S. AU - Pagnoux, C. AU - Martin Silva, N. AU - Renand, A. AU - Galateau-Salle, F. PY - 2010 DA - 2010// TI - Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-04-279240 DO - 10.1182/blood-2010-04-279240 ID - Aouba2010 ER - TY - JOUR AU - Myra, C. AU - Sloper, L. AU - Tighe, P. J. AU - McIntosh, R. S. AU - Stevens, S. E. AU - Gregson, R. H. PY - 2004 DA - 2004// TI - Treatment of Erdheim-Chester disease with cladribine: a rational approach JO - Br J Ophthalmol VL - 88 UR - https://doi.org/10.1136/bjo.2003.035584 DO - 10.1136/bjo.2003.035584 ID - Myra2004 ER - TY - JOUR AU - Dagna, L. AU - Corti, A. AU - Langheim, S. AU - Guglielmi, B. AU - Cobelli, F. AU - Doglioni, C. PY - 2012 DA - 2012// TI - Tumor necrosis factor alpha as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.41.9911 DO - 10.1200/JCO.2012.41.9911 ID - Dagna2012 ER - TY - JOUR AU - Haroche, J. AU - Amoura, Z. AU - Charlotte, F. AU - Salvatierra, J. AU - Wechsler, B. AU - Graux, C. PY - 2008 DA - 2008// TI - Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2008-03-148304 DO - 10.1182/blood-2008-03-148304 ID - Haroche2008 ER - TY - JOUR AU - Chester, W. PY - 1930 DA - 1930// TI - Uber lipoidgranulomatose JO - Virchows Arch Pathol Anat VL - 279 UR - https://doi.org/10.1007/BF01942684 DO - 10.1007/BF01942684 ID - Chester1930 ER - TY - JOUR AU - Veyssier-Belot, C. AU - Cacoub, P. AU - Caparros-Lefebvre, D. AU - Wechsler, J. AU - Brun, B. AU - Remy, M. PY - 1996 DA - 1996// TI - Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases JO - Medicine (Baltimore) VL - 75 UR - https://doi.org/10.1097/00005792-199605000-00005 DO - 10.1097/00005792-199605000-00005 ID - Veyssier-Belot1996 ER - TY - JOUR AU - Haroche, J. AU - Cohen-Aubart, F. AU - Emile, J. F. AU - Maksud, P. AU - Drier, A. AU - Toledano, D. PY - 2015 DA - 2015// TI - Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients With BRAFV600E-Mutated Erdheim-Chester Disease JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.1950 DO - 10.1200/JCO.2014.57.1950 ID - Haroche2015 ER - TY - JOUR AU - Haroche, J. AU - Charlotte, F. AU - Arnaud, L. AU - Deimling, A. AU - Helias-Rodzewicz, Z. AU - Hervier, B. PY - 2012 DA - 2012// TI - High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-05-430140 DO - 10.1182/blood-2012-05-430140 ID - Haroche2012 ER - TY - JOUR AU - Haroche, J. AU - Cohen-Aubart, F. AU - Emile, J. F. AU - Arnaud, L. AU - Maksud, P. AU - Charlotte, F. PY - 2013 DA - 2013// TI - Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-07-446286 DO - 10.1182/blood-2012-07-446286 ID - Haroche2013 ER - TY - JOUR AU - Tzoulis, C. AU - Gjerde, I. O. AU - Softeland, E. AU - Neckelmann, G. AU - Strom, E. AU - Vintermyr, O. K. PY - 2012 DA - 2012// TI - Erdheim-Chester disease presenting with an intramedullary spinal cord lesion JO - J Neurol VL - 259 UR - https://doi.org/10.1007/s00415-012-6544-0 DO - 10.1007/s00415-012-6544-0 ID - Tzoulis2012 ER - TY - JOUR AU - Berget, E. AU - Helgeland, L. AU - Molven, A. AU - Vintermyr, O. K. PY - 2011 DA - 2011// TI - Detection of clonality in follicular lymphoma using formalin-fixed, paraffin-embedded tissue samples and BIOMED-2 immunoglobulin primers JO - J Clin Pathol VL - 64 UR - https://doi.org/10.1136/jcp.2010.081109 DO - 10.1136/jcp.2010.081109 ID - Berget2011 ER - TY - JOUR AU - McArthur, G. A. AU - Chapman, P. B. AU - Robert, C. AU - Larkin, J. AU - Haanen, J. B. AU - Dummer, R. PY - 2014 DA - 2014// TI - Safety and efficacy of vemurafenib in BRAF (V600E) and BRAF (V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70012-9 DO - 10.1016/S1470-2045(14)70012-9 ID - McArthur2014 ER -